期刊文献+

回心康片抗心肌细胞缺氧损伤的作用及机制

The protective effect of Huixinkan tablets on cardiomyocytes injured by hypoxia and its mechanism of actions
原文传递
导出
摘要 目的:探讨回心康片抗大鼠心肌细胞缺氧损伤的作用及其机制。方法:建立体外大鼠乳鼠心肌细胞缺氧损伤模型。采用血清药理学方法,研究回心康片对细胞活力的影响;采用全自动生化分析仪检测谷胱甘肽(GSH)、一氧化氮(NO)含量;采用FLIPR Calcium4试剂盒检测药物对胞浆内钙离子浓度变化的影响。结果:回心康片对正常心肌细胞无明显影响,但可明显提高缺氧损伤心肌细胞的活力,降低NO水平,提高GSH活性,降低心肌细胞因缺氧损伤而造成的钙离子浓度升高,与缺氧损伤组比较差异具有统计学意义(P<0.05,P<0.01)。结论:回心康片能抗心肌细胞缺氧损伤,其机制可能与抗氧化和减轻钙超载有关。 OBJECTIVE To study the effect of Huixinkan tablets on cardiocytes injured by hypoxia and its mechanism of ac tions. METHODS Neonatal cardiomycytes were cultured and cytotoxicity in cultured cardiomyocytes was induced by hypoxia. Then, a method of serum pharmacology was used to study the effect of Huixinkan tablets on cell viability, which was analyzed using the MTT assay. GSH and NO activity in medium were assayed by automatic biochemistry analyzer and [ca^2+]i of cardio- myocytes loaded by Fluo-4 was analyzed by Multiskan Ascent immediately. RESULTS The tablets showed no significant effect on healthy cardiomyocytes. Huixinkan tablets increased the activities of the cells injured by hypoxia significantly. GSH and NO activities in medium and the intracellular calcium concentration dealed by Huixinkan tablets medicated serum were significantly different from the model group(P〈0. 05,P〈0.01). CONCLUSION Huixinkan tablets have protective effect on the myocardi al cells injuried by hypoxia, its mechanism may be associated with antioxidant and relieving calcium overload.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第14期1118-1121,共4页 Chinese Journal of Hospital Pharmacy
关键词 回心康 心肌细胞 缺氧 钙超载 Huixinkan tablets cardiomyocytes hypoxia
  • 相关文献

参考文献1

二级参考文献46

  • 1Lteif AA,Mather KJ,ClarkCM.Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes.Cardiol Rev 2003; 11:262-274.
  • 2Sowers JR,Epstein M,Frohlich ED.Diabetes,hypertension,and cardiovascular disease:an update.Hypertension 2001; 37:1053-1059.
  • 3Jackson CV,McGrath GM,Tahiliani AG,Vadlamudi RV,McNeill JH.A functional and ultrastructural analysis of experimental diabetic rat myocardium.Manifestation of a cardiomyopathy.Diabetes 1985; 34:876-883.
  • 4Bailey CJ,Turner RC,Metformin.N Engl J Med 1996; 334:574-579.
  • 5Effect of intensive blood-glucose control with metformin on complications in overweight patient with type 2 diabetes (UKPDS 34).UK Prospective Diabetes Study (UKPDS) Group.Lancet 1998; 352:854-865.
  • 6Kirpichnikov D,McFarlane SI,Sowers JR.Metformin:an update.Ann Intern Med 2002; 137:25-33.
  • 7United Kingdom Prospective Diabetes Study 24:a 6-year,randomized,controlled trial comparing sulfonylurea,insulin,and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy.United Kingdom Prospective Diabetes Study Group.Ann Intern Med 1998; 128:165-175.
  • 8Solskov L,Lofgren B,Kristiansen SB,Carr RD,Paiva M,Wynne AM,et al.Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration.Basic Clin Pharmacol Toxicol 2008; 103:82-87.
  • 9Bhamra GS,Hausenloy DJ,Davidson SM,Carr RD,Pavia M,Wynne AM,et al.Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.Basic Res Cardiol 2008; 103:274-284.
  • 10Calvert JW,Gundewar S,Jha S,Greer JJ,Bestermann WH,Tian R,et al.Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling.Diabetes 2008; 57:696-705.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部